Breaking News

As of February 26, 2024, Kerrisdale Capital has reiterated to Benzinga their position on Altimmune (ALT) – they remain bearish...

Tenaya Therapeutics has recently unveiled groundbreaking preclinical data in Nature Communications on their novel small molecule HDAC6 inhibitor, TN-301, designed...

On February 26, 2024, Owlet unveiled a new $9 million private placement financing deal. This will involve the issuance of...

Leerink Partners analyst Michael Cherny has just started covering GoodRx Holdings (NASDAQ: GDRX) with an optimistic Outperform rating and a...

Enlivex has recently obtained regulatory approval from Israel's Health Ministry to kick off a Phase 1/2 clinical study assessing Allocetra...

Susquehanna analyst Biju Perincheril has decided to maintain a Neutral rating on SM Energy (NYSE:SM) on February 26, 2024. However,...

NRx Pharmaceuticals has officially launched HOPE Therapeutics, Inc. during the BIO CEO & Investor Conference 2024. The company's management is...

Pilgrim's Pride stocks are on the rise today as investors react positively to the company's impressive fourth-quarter financial report. With...

Trust Stamp, a leading technology company, recently announced a major milestone on February 26, 2024. The USPTO granted a notice...

On February 26, 2024, Michael Cherny, an analyst at Leerink Partners, began covering Align Technology (NASDAQ: ALGN) with a Market...